AIM

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) is running for the top in the market this morning, and for good reason. The company announced statistically significant positive… Read More »AIM ImmunoTech (AIM) Stock On Significant Survival Data

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) is flying in the market this morning, and for good reason. The company announced a $14.54 million grant surrounding the… Read More »AIM ImmunoTech (AIM) Stock Rockets On Grant Funding

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) is headed up in the market this morning, trading on gains of more than 15% as it follows up on… Read More »AIM ImmunoTech (AIM) Stock Heads Up On Quarterly Results

Biomerica, Inc. (NASDAQ: BMRA) is making a dramatic run for the top in the market this morning. The stock is gaining in multiples after announcing… Read More »Biomerica (BMRA) Stock Gains In Multiples On COVID-19 Test News

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) is heading back up in the market this morning after a bit of profit taking yesterday. The wild ride in… Read More »AIM ImmunoTech (AIM) Stock Heads Back Up

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) has had an incredibly strong run in the market as of late, and those gains are continuing today. Today’s gains… Read More »AIM ImmunoTech (AIM) Stock Rockets On Coronavirus Treatment News

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) is runnning for the top in the market this morning, gaining more than 50% before the opening bell. The gains… Read More »AIM ImmunoTech (AIM) Stock Climbs On COVID-19 Collaboration

AIM ImmunoTech Inc (NYSEAMERICAN: AIM) is having a strong start to the trading session this morning, up more than 30% this morning. The gains come… Read More »AIM ImmunoTech (AIM) Stock Runs On Coronavirus News

I’ve followed AIM ImmunoTech (NYSEAMERICAN: AIM) for some time now and have been impressed with the idea that its drug Ampligen brings to the table.… Read More »AIM ImmunoTech (AIM) Stock: This Update Changes the Game